Great Valley Advisor Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Sell
18,393
-69,182
-79% -$4.78M 0.03% 415
2025
Q1
$6.08M Sell
87,575
-2,522
-3% -$175K 0.13% 159
2024
Q4
$7.75M Buy
90,097
+55,192
+158% +$4.75M 0.17% 129
2024
Q3
$4.16M Sell
34,905
-1,951
-5% -$232K 0.1% 206
2024
Q2
$5.26M Buy
36,856
+1,571
+4% +$224K 0.15% 151
2024
Q1
$4.53M Buy
35,285
+8,493
+32% +$1.09M 0.14% 164
2023
Q4
$2.77M Buy
26,792
+7,563
+39% +$783K 0.1% 195
2023
Q3
$1.75M Buy
19,229
+11,847
+160% +$1.08M 0.07% 236
2023
Q2
$597K Buy
7,382
+2,850
+63% +$230K 0.03% 406
2023
Q1
$360K Buy
4,532
+154
+4% +$12.2K 0.02% 494
2022
Q4
$296K Buy
4,378
+66
+2% +$4.46K 0.02% 547
2022
Q3
$215K Buy
4,312
+6
+0.1% +$299 0.01% 616
2022
Q2
$240K Buy
+4,306
New +$240K 0.01% 598
2019
Q2
Sell
-13,688
Closed -$358K 338
2019
Q1
$358K Buy
13,688
+230
+2% +$6.02K 0.11% 195
2018
Q4
$310K Buy
+13,458
New +$310K 0.12% 160